TMCnet News
Isracann Biosciences Announces OTC Trading Symbol Change to "ISCNF", Effective November 15, 2019VANCOUVER, British Columbia, Nov. 15, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (FRA: A2PT0E) (formerly OTC: ATLED) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both Israeli and European export sales, is pleased to announce that the Financial Industry Regulatory Authority, Inc. ("FINRA") has approved the Company’s request to change its OTC ticker symbol to ISCNF, effective as of the opening of market trading on November 15, 2019. The previous trading symbol was ATLED and has been changed to more accurately represent our corporate brand and primary operations in the cannabis sector. The Company is also pleased to announce that it has secured DTC eligibility by The Depository Trust Company ("DTC") for electronic settlement and transfer of its common shares in the United States. “Trading under the new OTC ticker symbol ISCNF and achieving DTC eligibility is a major step forward in making it materially easier for US-based investors who are intrigued by the idea of buying shares in an Israeli cannabis venture operated by sector experienced entrepreneurs and capital markets professionals. Our strategic aim is straightforward and leverages the national brand excellence of the Israeli agricultural industry combined with planned industrial scale production of low cost premium quality cannabis targeting export into the massive European marketplace. It’s a uniquely scalable venture that combines numerous positive attributes including a team that knows how to execute,” stated Darryl Jones, Company CEO. “This is an important step in propelling our story to wider audiences and to materially grow our investor base." No action is required to be taken by current shareholders with relation to the trading symbol change, and no changes have been made to the Company’s share capital, management, or control. Isrcann’s shares will continue to trade on the Canadian Securities Exchange (CSE) under the symbol CSE: IPOT, as well as the Frankfurt Stock Exchange under the symbol FRA: A2PT0E. Updates relating to the additional corporate changes mentioned above will be announced as initiatives continue to progress. ON BEHALF OF THE BOARD OF DIRECTORS “Darryl Jones” Darryl Jones About OTC Markets Group Inc. About the Depository Trust Company About Isracann Biosciences Inc. (CSE: IPOT) (FRA: A2PT0E) (OTC: ISCNF) The CSE does not accept responsibility for the adequacy or accuracy of this release. Contact |